Axogen, Inc. — Director's Dealing 2018

Feb 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-02-13

Reporting Person: Grooms Jamie Mark (Director, VP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-13	Common Stock	S	7100	$26.20	Disposed	202595	Indirect
2018-02-13	Common Stock	S	3200	$26.22	Disposed	9073	Indirect
2018-02-14	Common Stock	S	32936	$26.72	Disposed	169659	Indirect
2018-02-14	Common Stock	S	9073	$26.71	Disposed	0	Indirect
2018-02-15	Common Stock	S	43403	$27.11	Disposed	126256	Indirect

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee.

F4: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.